Reducing Toxicity in Drug Compound

26 - 27 January 2009, London,, United Kingdom

Introduction

Are you responsible for New Chemical Entity Development? Or just Reducing Toxicity levels later on? Then you will be aware that the majority of drugs fail to make it to market due to increase toxicity levels. Reducing Toxicity in Drug Compound, London, will enable drug discovery scientists, to analyse results and implement testing at a much earlier stage to limit cost and employ techniques to correctly identify lower toxic entities for further drug development.